Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease.
Abhinav VasudevanNina ParthasarathyDanny ConSteven NicolaidesRoss ApostolovAyushi ChauhanMaria BisharaRaphael P LuberNeetima JoshiAnna WanJames A RickardTony LongDeclan ConnoleyMiles Patrick SparrowPeter R GibsonDaniel R Van LangenbergPublished in: Alimentary pharmacology & therapeutics (2020)
Discontinuation of methotrexate occurred at rates twice that of dose-optimised thiopurine therapy.